EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Validation of the PrEP Use Self-Efficacy (PrEP-Use) Scale Among Sexual Minority Men

Juan A. Esquivel-Mendoza, Elliott R. Weinstein, Bharat Bharat, Nicolas Cardenas, Marc Puccinelli, Matthew J. Mimiaga, Christina Psaros, Susanne Doblecki-Lewis, Douglas Krakower, Kenneth Mayer, Steven A. Safren

AIDS Education and Prevention · 2025-10 · 37 (5) · 333-346

DOI: 10.1521/aeap.2025.37.5.333 ↗
AbstractBibliografische Angaben

Abstract

Self-efficacy may influence several stages of the PrEP care continuum, yet most validated measures capture only one component rather than a comprehensive approach. To address this gap, this study validated the PrEP Use Self-Efficacy (PrEP-USE) scale. Sexual minority men (N = 300) prescribed daily oral PrEP completed a baseline assessment including sociodemographics, the PrEP-USE scale, self-reported adherence, and PrEP-related variables (attitudes, stigma, subjective and descriptive norms) as part of a larger randomized controlled trial. Exploratory factor analysis identified a three-factor model (Challenges, Management, Routine) with acceptable fit. Overcoming challenges was associated with PrEP adherence (b = 1.09, p < .01) and correlated with all PrEP-related variables (p < .05). Management correlated with all variables (p < .05) but not adherence. Routine was associated with adherence (b = 2.42, p < .001) and only with PrEP attitudes (p < .05). Integrating the PrEP-USE scale into intervention frameworks may strengthen self-efficacy measurement.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →